Cargando…

SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer

SIMPLE SUMMARY: The penetration of various cell types into the tumor microenvironment plays an important role in cancer progression, including metastasis. SFMBT2, an epigenetic factor, is downregulated in metastatic prostate cancer. The aim of the current study is to evaluate the role of SFMBT2 in r...

Descripción completa

Detalles Bibliográficos
Autores principales: Gwak, Jungsug, Jeong, Hayan, Lee, Kwanghyun, Shin, Jee Yoon, Sim, Taejun, Na, Jungtae, Kim, Jongchan, Ju, Bong-Gun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565541/
https://www.ncbi.nlm.nih.gov/pubmed/32971847
http://dx.doi.org/10.3390/cancers12092718
_version_ 1783595956446429184
author Gwak, Jungsug
Jeong, Hayan
Lee, Kwanghyun
Shin, Jee Yoon
Sim, Taejun
Na, Jungtae
Kim, Jongchan
Ju, Bong-Gun
author_facet Gwak, Jungsug
Jeong, Hayan
Lee, Kwanghyun
Shin, Jee Yoon
Sim, Taejun
Na, Jungtae
Kim, Jongchan
Ju, Bong-Gun
author_sort Gwak, Jungsug
collection PubMed
description SIMPLE SUMMARY: The penetration of various cell types into the tumor microenvironment plays an important role in cancer progression, including metastasis. SFMBT2, an epigenetic factor, is downregulated in metastatic prostate cancer. The aim of the current study is to evaluate the role of SFMBT2 in regulating cell penetration into the prostate cancer microenvironment. Downregulation of SFMBT2 promotes infiltration of preadipocytes and TAMs by up-regulation of CXCL8, CCL2, CXCL10, and CCL20 expression. Expression of CXCL8, CCL2, CXCL10, and CCL20 is dependent on NF-κB activation in prostate cancer cells expressing low levels of SFMBT2. Moreover, increased IL-6 from infiltrated preadipocytes and TAMs further enhance migration and invasion of prostate cancer cells. Thus, SFMBT2 could be used as a novel biomarker and target for prostate cancer treatment. ABSTRACT: Infiltration of diverse cell types into tumor microenvironment plays a critical role in cancer progression including metastasis. We previously reported that SFMBT2 (Scm-like with four mbt domains 2) regulates the expression of matrix metalloproteinases (MMPs) and migration and invasion of cancer cells in prostate cancer. Here we investigated whether the down-regulation of SFMBT2 regulates the infiltration of preadipocytes and tumor-associated macrophages (TAMs) in prostate cancer. We found that the down-regulation of SFMBT2 promotes the infiltration of preadipocytes and TAMs through up-regulation of CXCL8, CCL2, CXCL10, and CCL20 expression in prostate cancer. Expression of CXCL8, CCL2, CXCL10, and CCL20 was also elevated in prostate cancer patients having a higher Gleason score (≥8), which had substantially lower SFMBT2 expression. We also found that the up-regulation of CXCL8, CCL2, CXCL10, and CCL20 expression is dependent on NF-κB activation in prostate cancer cells expressing a low level of SFMBT2. Moreover, increased IL-6 from infiltrated preadipocytes and TAMs promoted migration and invasion of prostate cancer cells expressing a low level of SFMBT2. Our study may suggest that SFMBT2 a critical regulator for the infiltration of preadipocytes and TAMs into the prostate tumor microenvironment. Thus, the regulation of SFMBT2 may provide a new therapeutic strategy to inhibit prostate cancer metastasis, and SFMBT2 could be used as a potential biomarker in prostate cancer metastasis.
format Online
Article
Text
id pubmed-7565541
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75655412020-10-26 SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer Gwak, Jungsug Jeong, Hayan Lee, Kwanghyun Shin, Jee Yoon Sim, Taejun Na, Jungtae Kim, Jongchan Ju, Bong-Gun Cancers (Basel) Article SIMPLE SUMMARY: The penetration of various cell types into the tumor microenvironment plays an important role in cancer progression, including metastasis. SFMBT2, an epigenetic factor, is downregulated in metastatic prostate cancer. The aim of the current study is to evaluate the role of SFMBT2 in regulating cell penetration into the prostate cancer microenvironment. Downregulation of SFMBT2 promotes infiltration of preadipocytes and TAMs by up-regulation of CXCL8, CCL2, CXCL10, and CCL20 expression. Expression of CXCL8, CCL2, CXCL10, and CCL20 is dependent on NF-κB activation in prostate cancer cells expressing low levels of SFMBT2. Moreover, increased IL-6 from infiltrated preadipocytes and TAMs further enhance migration and invasion of prostate cancer cells. Thus, SFMBT2 could be used as a novel biomarker and target for prostate cancer treatment. ABSTRACT: Infiltration of diverse cell types into tumor microenvironment plays a critical role in cancer progression including metastasis. We previously reported that SFMBT2 (Scm-like with four mbt domains 2) regulates the expression of matrix metalloproteinases (MMPs) and migration and invasion of cancer cells in prostate cancer. Here we investigated whether the down-regulation of SFMBT2 regulates the infiltration of preadipocytes and tumor-associated macrophages (TAMs) in prostate cancer. We found that the down-regulation of SFMBT2 promotes the infiltration of preadipocytes and TAMs through up-regulation of CXCL8, CCL2, CXCL10, and CCL20 expression in prostate cancer. Expression of CXCL8, CCL2, CXCL10, and CCL20 was also elevated in prostate cancer patients having a higher Gleason score (≥8), which had substantially lower SFMBT2 expression. We also found that the up-regulation of CXCL8, CCL2, CXCL10, and CCL20 expression is dependent on NF-κB activation in prostate cancer cells expressing a low level of SFMBT2. Moreover, increased IL-6 from infiltrated preadipocytes and TAMs promoted migration and invasion of prostate cancer cells expressing a low level of SFMBT2. Our study may suggest that SFMBT2 a critical regulator for the infiltration of preadipocytes and TAMs into the prostate tumor microenvironment. Thus, the regulation of SFMBT2 may provide a new therapeutic strategy to inhibit prostate cancer metastasis, and SFMBT2 could be used as a potential biomarker in prostate cancer metastasis. MDPI 2020-09-22 /pmc/articles/PMC7565541/ /pubmed/32971847 http://dx.doi.org/10.3390/cancers12092718 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gwak, Jungsug
Jeong, Hayan
Lee, Kwanghyun
Shin, Jee Yoon
Sim, Taejun
Na, Jungtae
Kim, Jongchan
Ju, Bong-Gun
SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer
title SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer
title_full SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer
title_fullStr SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer
title_full_unstemmed SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer
title_short SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer
title_sort sfmbt2-mediated infiltration of preadipocytes and tams in prostate cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565541/
https://www.ncbi.nlm.nih.gov/pubmed/32971847
http://dx.doi.org/10.3390/cancers12092718
work_keys_str_mv AT gwakjungsug sfmbt2mediatedinfiltrationofpreadipocytesandtamsinprostatecancer
AT jeonghayan sfmbt2mediatedinfiltrationofpreadipocytesandtamsinprostatecancer
AT leekwanghyun sfmbt2mediatedinfiltrationofpreadipocytesandtamsinprostatecancer
AT shinjeeyoon sfmbt2mediatedinfiltrationofpreadipocytesandtamsinprostatecancer
AT simtaejun sfmbt2mediatedinfiltrationofpreadipocytesandtamsinprostatecancer
AT najungtae sfmbt2mediatedinfiltrationofpreadipocytesandtamsinprostatecancer
AT kimjongchan sfmbt2mediatedinfiltrationofpreadipocytesandtamsinprostatecancer
AT jubonggun sfmbt2mediatedinfiltrationofpreadipocytesandtamsinprostatecancer